GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ablynx NV (XBRU:ABLXS) » Definitions » FCF Yield %

Ablynx NV (XBRU:ABLXS) FCF Yield % : -1.73 (As of Jun. 16, 2024)


View and export this data going back to . Start your Free Trial

What is Ablynx NV FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ablynx NV's Trailing 12-Month Free Cash Flow is €0.00 Mil, and Market Cap is €0.04 Mil. Therefore, Ablynx NV's FCF Yield % for today is -1.73%.

The historical rank and industry rank for Ablynx NV's FCF Yield % or its related term are showing as below:

XBRU:ABLXS' s FCF Yield % Range Over the Past 10 Years
Min: -16.99   Med: -6.98   Max: 30.96
Current: -1.73


During the past 12 years, the highest FCF Yield % of Ablynx NV was 30.96%. The lowest was -16.99%. And the median was -6.98%.

XBRU:ABLXS's FCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -13.865 vs XBRU:ABLXS: -1.73

Ablynx NV's FCF Margin % for the quarter that ended in Dec. 2017 was -143.17%.


Ablynx NV FCF Yield % Historical Data

The historical data trend for Ablynx NV's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ablynx NV FCF Yield % Chart

Ablynx NV Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ablynx NV Semi-Annual Data
Dec07 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ablynx NV's FCF Yield %

For the Biotechnology subindustry, Ablynx NV's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ablynx NV's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ablynx NV's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ablynx NV's FCF Yield % falls into.



Ablynx NV FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ablynx NV's FCF Yield % for the fiscal year that ended in Dec. 2017 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-60.652 / 0
=N/A%

Ablynx NV's annualized FCF Yield % for the quarter that ended in Dec. 2017 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-29.918 * 2 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ablynx NV FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ablynx NV FCF Yield % Related Terms

Thank you for viewing the detailed overview of Ablynx NV's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ablynx NV (XBRU:ABLXS) Business Description

Traded in Other Exchanges
N/A
Address
Ablynx NV is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. It has 45 proprietary and partnered programs in development in various therapeutic areas including inflammation, hematology, immuno-oncology, oncology and respiratory disease. It has collaborations with multiple pharmaceutical companies including AbbVie; Boehringer Ingelheim; Eddingpharm; Merck & Co., Inc., Kenilworth, New Jersey, USA; Merck KGaA; Novartis; Novo Nordisk; Sanofi and Taisho Pharmaceuticals. The company generates revenue from research collaboration agreements and from government grants.

Ablynx NV (XBRU:ABLXS) Headlines

No Headlines